Open, Prospective, Multi-Center, Two-Part Study of Patient Preference with Monthly Ibandronate Therapy in Women with Postmenopausal Osteoporosis Switched From Daily or Weekly Alendronate or Risendronate-BONCURE: Results of Turkish Sub-Study

Eskiyurt, Nurten; Irdesel, Jale; Sepici, Vesile; Ugurlu, Hatice; KİRAZLI, YEŞİM; ARDIÇ, FÜSUN; BÜTÜN, BÜLENT; Akyuz, Gulseren; Cerrahoglu, Lale; ŞENDUR, ÖMER; Yalcin, Peyman; Oncel, Sema; Saridogan, Merih; SARPEL, TUNAY; Tosun, Mehmet; Kutsal, Yesim; Senel, Kazim; Gursoy, Savas; Canturk, Ferhan; DEMİR, HÜSEYİN; Ozdener, Fatih; Oncel, Hakan

doi:10.4274/tod.29491

Open, Prospective, Multi-Center, Two-Part Study of Patient Preference with Monthly Ibandronate Therapy in Women with Postmenopausal Osteoporosis Switched From Daily or Weekly Alendronate or Risendronate-BONCURE: Results of Turkish Sub-Study

Eskiyurt N., Irdesel J., Sepici V., Ugurlu H., KİRAZLI Y., ARDIÇ F., ...Daha Fazla

TURK OSTEOPOROZ DERGISI-TURKISH JOURNAL OF OSTEOPOROSIS, cilt.18, sa.1, ss.1-7, 2012 (ESCI, Scopus, TRDizin)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 18 Sayı: 1
Basım Tarihi: 2012
Doi Numarası: 10.4274/tod.29491
Dergi Adı: TURK OSTEOPOROZ DERGISI-TURKISH JOURNAL OF OSTEOPOROSIS
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.1-7
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Hacettepe Üniversitesi Adresli: Evet

Özet

Aim: BONCURE (Bonviva for Current Bisphosphonate Users Regional European Trial), aimed to evaluate patient preference with monthly ibandronate in women with postmenopausal osteoporosis who previously received daily or weekly alendronate or risendronate.